inVentiv Health launches new European shop

Share this article:
49331_ncgsmc_gsw_wht_paper_16

Healthcare marketing agency inVentiv Health has further extended its breadth of services to the European market with the launch of a new shop called inVentiv Health Communications/Europe.

The new agency will be led by Bob Chandler, founder of Chandler Chicco Companies and SVP, marketing and communications at inVentiv Health. Headquartered in London, inVentiv Health Communications/Europe will now encompass previously established inVentiv Euro shops GSW Europe and Junction 11, in addition to the organization's new branch.

“The power of the well-regarded assets of inVentiv Health Communications/Europe, now working in greater unison, will have a profound impact on how we tackle opportunities emerging every day in the evolving European healthcare environment,” said Chandler in a statement. “Our new way of going to market is designed to facilitate a multidisciplinary approach to driving plans and programs that reach intended target audiences with greater speed and relevancy. We believe this efficiency will generate financial savings for our clients.”  

inVentiv Health has also released its Q2 financial information, reportedly earning $220.5 million in net revenue for the company's commercial business as of June 30 this year, a 14% increase since Q2 2010. Part of this sum is accounted for in inVentiv's acquisition of pharma and biotech consulting firm Campbell Alliance, which the company purchased this past February.

Share this article:

Email Newsletters

More in News

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.